By Blood-Horse Staff Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15. The studies will examine the pathophysiology of EIPH, or bleeding in horses' lungs. The condition is currently treated with furosemide, also known
By Ron Mitchell The Administrative Regulation Review Subcommittee of the Kentucky legislature has voted 6-2 to find a proposed regulation permitting racetracks the option of carding furosemide-free races "deficient." Furosemide, commonly known as Salix or Lasix, is a widely-used anti-diuretic medication. In a release, the Kentucky Horsemen's Benevolent and Protective Association said the 6-2 vote
By Jeremy Balan The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding the potential employment of third-party furosemide administration in the state, but any change in procedures still likely won't occur until 2016. After the CHRB sent a proposal on third-party administration of furosemide, commonly known as
By Tom LaMarra The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks. The board of directors met Aug. 29 and approved the measure, the CTT said in a release. The organization also said it supports third-party
By Tom LaMarra In March 2013 eight states in the Mid-Atlantic and Northeast—Delaware, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Virginia, and West Virginia—announced their intentions to adopt uniform regulations governing equine medication rules and drug testing. The effort, spearheaded by the Thoroughbred Horsemen's Association, which represents owners and trainers in many states in the
By Edited Press Release Members of the California Horse Racing Board (CHRB) and California horse racing industry leaders are reaffirming their support for the concept of third-party furosemide (also called Salix or Lasix) administration as part of the National Uniform Medication Program, while offering reassurance that a vote by the board on Aug. 20 to
By T. D. Thornton Bruce Seymore, the executive director of Arapahoe Park, is a bit of a maverick racetrack operator. His Colorado oval is geographically isolated from other racing venues, and when Seymore senses he has a good idea to bolster the product at his three-month mixed Thoroughbred, Quarter Horse and Arabian meet, he doesn’t
RMTC By Tom LaMarra An effort that began in the Mid-Atlantic region more than two years ago has made "significant progress," according to the Racing Medication and Testing Consortium. Adoption of the National Uniform Medication Program hasn't been without its twists and turns, but given the fractured nature of the Thoroughbred industry and the need
NEWS RELEASE July 7, 2015 Contact: Hallie Roach Lewis (859) 224-2848 MID-YEAR UPDATE: SIGNIFICANT PROGRESS MADE IN ADOPTION OF NATIONAL UNIFORM MEDICATION PROGRAM In the last six months, the horse racing industry made significant progress toward the uniform adoption of a national medication program, as regulators in a number of additional jurisdictions adopted reforms developed
RMTC By T. D. Thornton Don’t expect to see any Lasix-free races soon in the Golden State, but the California Horse Racing Board is zeroing in on proactive ways to head off other "emerging threats" to equine welfare, like requiring post-mortem reviews of all on-track fatalities, focusing on quality instead of quantity when it comes
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
